Purchase Order W81K0018P0244
Award Date 4/1/18
Potential Completion Date 10/31/20
Potential Value $98K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Colorado Springs, CO 80913, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price purchase order contract awarded by the U.S. Army Medical Command to Veracyte, Inc., a for-profit organization that provides genomic testing services. The contract, valued at $96,176.63, is for the provision of supply/service in support of the agency's cancer detection and diagnosis efforts. Veracyte holds an Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicle with the Veterans Health Administration's Veterans Integrated Service Network 23, valued at up to...
- This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 16 to Veracyte, Inc., a for-profit medical diagnostic company. The $165,200.00 contract is for the delivery of AFIRMA testing services to the Fayetteville VA Medical Center from April 1, 2026 through April 30, 2027, with a potential completion date of April 30, 2029. Veracyte will provide specialized genomic testing services to support precision medicine and informed...
- This firm fixed-price purchase order for $77,700 was awarded by the Veterans Integrated Service Network 8 (VISN 8) of the U.S. Department of Veterans Affairs to Veracyte, Inc., a for-profit provider of genomic testing services. The contract is for Afirma Gene Expression Classifier and Atlas Expression Classifier testing, which analyze gene expression patterns in thyroid biopsy samples to determine malignancy risk and aid in diagnosis and treatment decisions for veterans. This award is not set...
- The Department of the Army Medical Command awarded a $165,263.60 firm fixed price purchase order to Veracyte, Inc. to provide Afirma Genomic Sequencing Classifier (GSC) testing services. The testing will be conducted at Veracyte's facility in South San Francisco, California under a three year period of performance starting October 2020. The original solicitation sought market research to identify potential sources for this testing requirement, noting the government's intent to award sole...
- This is a firm fixed-price definitive contract awarded by the Department of Veterans Affairs (VA) to Veracyte, Inc., a for-profit medical diagnostic company based in South San Francisco, California. The contract is for $593,715.57 and provides specialty genomic laboratory testing services, primarily focused on cancer detection, diagnosis, and treatment planning through advanced gene expression analysis. The contract is awarded under the VA's Medical Laboratory Testing and Analysis Services...
- This is a $141,132.01 firm fixed price contract awarded by the Veterans Health Administration's Veterans Integrated Service Network 8 (VISN 8) to Veracyte, Inc., a for-profit provider of genomic testing services. The contract is for cancer screening tests, with no set-aside designation. Veracyte has also been awarded an Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicle from VISN 23 to provide reference laboratory services, with a potential value of $600,000 through April 2028....
- This federal contract award is for AFIRMA GENOMIC SEQUENCING CLASSIFIER LABORATORY TESTING services provided by Veracyte, Inc. to the Defense Health Agency. The contract is a Firm Fixed Price Delivery Order under Veracyte's Indefinite Delivery Indefinite Quantity contract vehicle with the Veterans Health Administration's VISN 23 network, which has a potential value of $600,000 through April 2028. Veracyte will perform the laboratory testing services at its facilities in South San Francisco,...
- This firm fixed-price purchase order was awarded by the Veterans Integrated Service Network 16 (VISN 16) of the U.S. Department of Veterans Affairs to Veracyte, Inc., a for-profit provider of genomic testing services, to conduct referral laboratory testing for thyroid genomic expression classifier (GEC) testing. The $202,552.00 contract has a period of performance through September 30, 2024. Veracyte has provided similar genomic testing services to support cancer detection and diagnosis for...
- This is a federal contract award to Veracyte, Inc., a for-profit medical diagnostics company, by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 16 (VISN 16). The contract is for $405,018.00 and involves the provision of genomic testing services, specifically Veracyte's proprietary genomic testing products and services. This is a firm fixed-price purchase order contract with a period of performance ending on May 31, 2029. The contract is not set aside and appears to...
- This is a firm fixed-price delivery order contract awarded by the Veterans Integrated Service Network 23 (VISN 23) to Veracyte, Inc., a for-profit medical diagnostic company, for reference laboratory services. The contract has a ceiling value of $86,000.00 and a performance period ending on April 30, 2026. Veracyte provides specialized genomic testing services, including the Decipher Prostate Cancer Test, Afirma Genomic Sequencing Classifier, and testing for conditions like idiopathic...